The same group confirmed these results using an exosomal miR-34a/b/c panel in an independent cohort of 89 HB patients, observing that the prognostic value of a panel of serum exosomal miRNAs including miR-34a/b/c was superior to other risk factors such as AFP. The gene discussed is AFP; the disease is hemoglobin measurement.